Thus, PD-1 inhibits antigen-nonspecific bystander T cell activation responses in vivo following viral infection but also suppresses AICD, and these can be overridden with checkpoint blockade, resulting in increased activation and antiviral effector functions in the complete absence of antigen-specific T cell activity. This evidence concerns the gene PDCD1 and viral infectious disease.